These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3511858)

  • 1. Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus.
    Newton RC; Jorizzo JL; Solomon AR; Sanchez RL; Daniels JC; Bell JD; Cavallo T
    Arch Dermatol; 1986 Feb; 122(2):170-6. PubMed ID: 3511858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoglobulin deposits in vascular walls in cutaneous lupus erythematosus. Immunofluorescence study].
    Neumann HA; Berretty PJ; Faber WR
    Ann Dermatol Venereol; 1982; 109(8):649-53. PubMed ID: 6764864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
    Ruzicka T; Meurer M; Bieber T
    Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies.
    Synkowski DR; Provost TT
    J Rheumatol; 1983 Dec; 10(6):920-4. PubMed ID: 6607342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
    Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
    Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of oral isotretinoin in the treatment of cutaneous lupus erythematosus].
    Vena GA; Coviello C; Angelini G
    G Ital Dermatol Venereol; 1989 Jun; 124(6):311-5. PubMed ID: 2630441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative histological, histo-immunological and ultrastructural study of healthy and pathological skin in acute disseminated lupus erythematosus and chronic lupus erythematosus].
    Lambert D; Justrabo E; Perrot H; Schmitt D; Cabanne F; Chapuis JL; Michiels R; Thivolet J
    Ann Anat Pathol (Paris); 1973; 18(4):419-36. PubMed ID: 4601805
    [No Abstract]   [Full Text] [Related]  

  • 8. Keratotic lupus erythematosus: treatment with isotretinoin.
    Rubenstein DJ; Huntley AC
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):910-4. PubMed ID: 3458729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ identification of mononuclear cells in cutaneous infiltrates in discoid lupus erythematosus, sarcoidosis and secondary syphilis.
    Bjerke JR; Krogh HK; Matre R
    Acta Derm Venereol; 1981; 61(5):371-80. PubMed ID: 6172923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposits of immunoglobulins and complement in oral lupus erythematosus.
    Schiödt M; Dabelsteen E; Ullman S; Halberg P
    Scand J Dent Res; 1974; 82(8):603-7. PubMed ID: 4217941
    [No Abstract]   [Full Text] [Related]  

  • 12. Subpopulations of mononuclear cells in lesions of psoriasis, lichen planus and discoid lupus erythematosus studied using monoclonal antibodies.
    Bjerke JR
    Acta Derm Venereol; 1982; 62(6):477-83. PubMed ID: 6187151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE; Sangle S; Harrison P; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of hypertrophic lupus erythematosus with isotretinoin.
    Green SG; Piette WW
    J Am Acad Dermatol; 1987 Aug; 17(2 Pt 2):364-8. PubMed ID: 3476521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous manifestations of systemic lupus erythematosus.
    Yell JA; Mbuagbaw J; Burge SM
    Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus.
    Vandersteen PR; Jordon RE
    Arch Dermatol; 1974 Jul; 110(1):95-8. PubMed ID: 4607646
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic discoid lupus erythematosus: an immunopathological and electron microscopic study.
    Shahidullah M; Lee YS; Khor CJ; Ratnam KV
    Ann Acad Med Singap; 1995 Nov; 24(6):789-92. PubMed ID: 8838982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of isotretinoin in six patients with cutaneous T-cell lymphoma.
    Neely SM; Mehlmauer M; Feinstein DI
    Arch Intern Med; 1987 Mar; 147(3):529-31. PubMed ID: 3493744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photochemotherapy in cutaneous lupus erythematosus.
    Wollina U; Looks A
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):127-30. PubMed ID: 10568493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.